- Your Challenges
- Offerings
- News & Events
- Knowledge Center
- About Us
- Diagnostics
CE Marked
For In Vitro Diagnostic Use
Abbott Molecular offers consolidated hepatitis testing of both HCV genotype and viral load on the fully automated Abbott m2000sp/rt platform. The Abbott Realtime Genotype II assay determines the genotypes of hepatitis C virus in plasma and serum of HCV-infected individuals.
The Abbott RealTime HCV Genotype II provides:
The Abbott RealTime HCV Genotype II assay consists of 2 reagent kits:
Assay Accuracy
The accuracy of the Abbott RealTime HCV Genotype II assay was demonstrated by testing 169 HCV genotype 1 (110 of genotype 1a, 58 of subtype 1b, and 1 genotype 1 only), 41 HCV genotype 2, 27 HCV genotype 3, 28 HCV genotype 4, 14 HCV genotype 5, and 12 HCV genotype 6 positive specimens. Nucleotide sequencing was used to determine the reference genotype of each specimen tested.
HVC GENOTYPE/SUBTYPE | NUMBERS SAMPLES TESTED | NUMBERS SAMPLES CORRECTLY IDENTIFIED | DETECTION RATE (%) |
1* | 169 | 169 | 100.00 |
1a** | 110 | 107 | 97.27 |
1b*** | 58 | 56 | 96.55 |
2 | 41 | 41 | 100.00 |
3 | 27 | 27 | 100.00 |
4**** | 28 | 28 | 89.29 |
5 | 14 | 14 | 100.00 |
6 | 12 | 10 | 83.33 |
1 though 6‡ | 291 | 286 | 98.28 |
Intended Use
The Abbott RealTime HCV Genotype II is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for determining the genotype(s) of hepatitis C virus (HCV) in plasma and serum from HCV-infected individuals. The Abbott RealTime HCV Genotype II assay detects genotypes 1, 2, 3, 4, 5, and 6, and subtypes 1a and 1b through the use of genotype-specific fluorescent-labeled oligonucleotide probes. The Abbott RealTime HCV Genotype II is not for screening blood, plasma serum or tissue donors for HCV, or to be used as a diagnostic test to confirm the presence of HCV infection.
References
1. Abbott RealTime HCV Genotype II [package insert]. Abbott Laboratories, 2013.
Target Region
The Abbott RealTime HCV Genotype II assay detects genotypes 1, 2, 3, 4, 5, and 6, and subtypes 1a and 1b through the use of genotype-specific fluorescent-labeled oligonucleotide probes. It targets the 5'UTR for the classification of HCV genotypes 1, 2, 3, 4, 5, and 6, and the NS5B region to accurately subtype HCV genotypes 1a and 1b.
Genotype Detection
The assay requires three separate reactions per sample to detect genotypes 1,2,3,4,5, and 6 and subtypes 1a and 1b:
Abbott RealTime HCV Genotype II assay performance* | |
Sensitivity | 500 IU/mL (0.5 mL prep) |
Specificity | 100%** |
Target Region | 5'UTR & NS5b |
Genotype Detection | 1a (NS5b), 1b (NS5b), 1, 2, 3, 4, 5, 6 (5'UTR) |
Standardization | Second World Health Organization Standard for Hepatitis C Virus RNA |
Internal Control | Yes; processed through sample prep with each sample |
External Control | Yes; Negative, Positive |
Results Reported | Qualitative - Genotype Call |
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.